Search

everythinglearnresearchcommunity

for

Search:↓

Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Aloe vera 10% effectively heals sheep wounds.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Gut microbiota influences the development of alopecia areata.

Patients with Alopecia Areata often have higher anxiety and depression.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

New genetic discoveries may lead to better treatments for alopecia areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

A 16-year-old boy's alopecia areata progressed unusually to resemble male pattern baldness.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

The document discusses a special exam case for formulating and using systemic therapy named Athena.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.

Black and Hispanic women are more likely to have alopecia areata than white women.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Unmarried individuals and those with diabetes have a poorer quality of life with alopecia areata.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.

AB+ blood group is more common in alopecia areata patients.